相关实验视频

Updated: Jan 9, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

开启了转移性子宫内膜癌与KRAS G12C突变的新治疗可能性

Bana Antonios¹, Oyepeju Abioye², Seon Jo Park¹

¹Allegheny Health Network-Allegheny General, Pittsburgh, Pennsylvania, USA.

Case reports in oncological medicine

|December 8, 2025

概括

使用阿达格拉西布的向治疗对晚期子宫内膜癌有希望. 这种KRAS G12C抑制剂为患有这种具有挑战性的妇科恶性瘤的患者提供了潜在的新治疗选择.

科学领域:

妇科瘤学妇科瘤学
医学遗传学医学遗传学
药理学药理学是指药理学的学科.

背景情况:

子宫内膜癌 (EC) 是一种异质性癌症,对于复发性或转移性疾病的治疗选择有限.
克拉斯突变,包括可向的克拉斯G12C变异,在EC病例的一个子集中被发现.
克拉斯G12C抑制剂已在其他固体瘤中表现出有效性,但在欧盟有有限的数据.

研究的目的:

在转移性子宫内膜透明细胞癌中报告对阿达格拉西布持续反应的病例.
突出KRAS G12C抑制剂在治疗晚期结核病中的潜力.
强调分子分析对识别可操作突变的重要性.

主要方法:

一个77岁的妇女患有转移性子宫内膜透明细胞癌的病例报告.
在多种标准疗法进展后使用阿达格拉西布治疗.
在欧洲共同体对KRAS G12C抑制剂现有文献的综述.

主要成果:

患者获得了对阿达格拉西布的持续反应.
这种反应发生在多个先前的治疗线路失败后.
这一案例增加了在欧洲共同体支持KRAS G12C抑制剂的有限证据.

结论:

在KRAS G12C突变的高级EC患者中,Adagrasib可能是一个可行的向治疗选择.
分子分析对于识别可能受益于KRAS G12C抑制剂的患者至关重要.
需要进一步的临床研究来确定这些药物在EC治疗中的作用.

关键词:

在KRAS G12C中使用.它们是有侵略性的.这是子宫内膜癌的癌症.有针对性的治疗.

更多相关视频

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...